RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,879 | -57.4% | 46,651 | 0.0% | 0.00% | – |
| Q2 2023 | $51,316 | -6.7% | 46,651 | 0.0% | 0.00% | – |
| Q1 2023 | $55,000 | +66.7% | 46,651 | +92.3% | 0.00% | – |
| Q4 2022 | $33,000 | -44.1% | 24,255 | -33.3% | 0.00% | – |
| Q3 2022 | $59,000 | +168.2% | 36,358 | +29.6% | 0.00% | – |
| Q2 2022 | $22,000 | -56.0% | 28,054 | 0.0% | 0.00% | – |
| Q1 2022 | $50,000 | +6.4% | 28,054 | -13.1% | 0.00% | – |
| Q4 2021 | $47,000 | -28.8% | 32,280 | 0.0% | 0.00% | – |
| Q3 2021 | $66,000 | +37.5% | 32,280 | +52.2% | 0.00% | – |
| Q2 2021 | $48,000 | -23.8% | 21,207 | 0.0% | 0.00% | – |
| Q1 2021 | $63,000 | +37.0% | 21,207 | +30.0% | 0.00% | – |
| Q4 2020 | $46,000 | – | 16,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |